Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Transport Secretary reveals overhaul of aging pneumatic transport systems

Better Choice Company announces SRX Health closure

A prisoner of political nostalgia for a time that no one understands, left or right, Harris or Trump | Raphael Behr

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » GSK expands operations in Lancaster County
Vaccines

GSK expands operations in Lancaster County

Paul E.By Paul E.October 24, 2024No Comments3 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


It’s bringing hundreds of millions of dollars and hundreds of new jobs to Lancaster County. Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its Marietta location, creating 200 jobs and doubling the size of the facility. ”This will be the largest scale for GSK. “The investment we’ve made in manufacturing in the United States is unprecedented,” said Maya Martinez-Davis, president of GSK. This investment will allow the company to expand both its manufacturing and research and development capabilities. “We know that an investment in prevention is the best investment. We know the impact and importance of prevention,” Martinez-Davis said. The state is supporting the project with grants and incentives. “This is one of the largest life science transactions in Pennsylvania history.” “This is the largest Commonwealth-supported economic development project in the history of Lancaster County,” Gov. Josh Shapiro told me about this. This project will have far-reaching implications. The equipment used by companies like GSK, the energy producers who produce the electricity needed to keep vaccines cold and the equipment running, and the farmers who produce the eggs often needed for vaccines. ” said Shapiro. GSK says one in four Americans has used a vaccine made in Marietta. Expansion work is expected to begin next week and be completed in 2028.

MARIETTA, PA —

It brings hundreds of millions of dollars and hundreds of new jobs to Lancaster County.

Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its Marietta location, creating 200 jobs and doubling the size of the facility.

“For GSK, this is the largest manufacturing investment we have ever made in the United States,” said GSK President Maya Martinez-Davis.

This investment will allow the company to expand both its manufacturing and research and development capabilities.

“We know that investing in prevention is the best investment we can make. We know the impact and importance of prevention,” Martinez-Davis said.

The state is supporting the project with $21 million in grants and incentives.

“This is one of the largest life science transactions in Pennsylvania history. And hear me out about this: This is the largest federally supported economic development project in Lancaster County history,” said Governor Josh Shapiro.

This project will have far-reaching implications.

“From the manufacturing industries here in the Commonwealth that supply the vials and some of the equipment that companies like GSK use, to the energy producers that produce the electricity needed to keep vaccines cold and equipment running; And all the way to the farmers. They’re the ones producing the eggs that are often needed for vaccines,” Shapiro said.

One in four Americans has used a vaccine made in Marietta, according to GSK.

Expansion work is expected to begin next week and be completed in 2028.



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleTrump, Harris polls; Beyoncé to perform
Next Article Jim Cramer explains why fossil fuels remain essential as Big Tech boom continues – NBC 5 Dallas-Fort Worth
Paul E.
  • Website

Related Posts

Kentucky leaders emphasize whooping cough vaccination

October 31, 2024

Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial

October 31, 2024

Trust is important, but increasing vaccination rates also requires three things

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Transport Secretary reveals overhaul of aging pneumatic transport systems

Better Choice Company announces SRX Health closure

A prisoner of political nostalgia for a time that no one understands, left or right, Harris or Trump | Raphael Behr

Harris and Trump ‘razor race’ in Michigan

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.